Blood test for lung infections in ventilated patients
Part of Infections, Lungs & breathing clinical trials.
This study looks at whether a simple blood test can help diagnose and predict the outcome of lung infections that happen while a patient is on a breathing machine. It compares a newer blood marker (heparin binding protein) with standard platelet tests to see which is more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and under 70 years old
- On a breathing machine (ventilator) for more than 48 hours
- Signs of a lung infection after being on the ventilator, with a score of 6 or higher on a lung infection scale
- No known infection or sepsis before being admitted to the intensive care unit (ICU)
- No cancer, chronic liver or kidney disease, or other conditions that affect blood platelets
- No severe low platelet count or recent platelet transfusion
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This study compares two blood tests—procalcitonin and zinc levels—to see which better detects pneumonia that develops while on a ventilator. The goal is to find a faster, more accurate way to diagnose this serious infection in ICU patients.
This study looks at changes (biomarkers) in the blood or other samples from people on a breathing machine. It may help doctors detect ventilator-associated pneumonia earlier and tailor treatment sooner.
This study looks at whether certain blood tests, called platelet indices, can help predict blood clots in the legs (deep vein thrombosis) and overall outcomes in patients who are on a breathing machine in the intensive care unit. It aims to find early warning signs that could lead to better prevention and treatment.
Hear when a new Ventilator Associated Pneumonia (VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.